MIR9-1HG: A Potential Drug Target and Biomarker (G10485)

Target Name: MIR9-1HG

NCBI ID: G10485

MIR9-1HG

MIR9-1HG: A Potential Drug Target and Biomarker

MIR9-1HG, also known as C1orf61, is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of theintsine proteasome subfamily 6.1 and is localized to the endoplasmic reticulum (ER) and cytoplasm. MIR9-1HG has been shown to play a role in various cellular processes, including cell signaling, DNA replication, and stress response.

Recent studies have suggested that MIR9-1HG may have potential as a drug target or biomarker. One reason for this is the fact that MIR9-1HG has been shown to interact with various drug molecules, including small molecules, peptides, and proteins. Additionally, MIR9-1HG has been shown to play a role in the regulation of cellular processes that are often disrupted in diseases, such as cancer, neurodegenerative diseases, and chronic obstructive pulmonary disease (COPD).

One potential mechanism by which MIR9-1HG may be a drug target is its role in cell signaling. MIR9-1HG has been shown to play a role in the regulation of T cell proliferation and differentiation, as well as in the regulation of cytokine signaling. MIR9-1HG has also been shown to interact with the proteinPD-L1, which is a known drug target for cancer. The interaction between MIR9-1HG and PD-L1 has been shown to enhance the effects of PD-L1 inhibitors, suggesting that MIR9-1HG may be a useful target for cancer treatment.

Another potential mechanism by which MIR9-1HG may be a drug target is its role in the regulation of DNA replication. MIR9-1HG has been shown to play a role in the regulation of DNA replication, including the loading of the DNA replication complex onto the nuclear chromatin. MIR9-1HG has also been shown to interact with the proteinDNMT, which is involved in the regulation of DNA replication. The interaction between MIR9-1HG and DNA replication complex has been shown to enhance the effects of DNA replication inhibitors, suggesting that MIR9-1HG may be a useful target for cancer treatment.

In addition to its potential role in drug targets, MIR9-1HG has also been shown to have potential as a biomarker. One reason for this is the fact that MIR9-1HG is expressed in various tissues of the body and can be used as a protein biomarker for various diseases. For example, MIR9-1HG has been used as a biomarker for cancer, as it has been shown to be upregulated in various types of cancer. Additionally, MIR9-1HG has been shown to be downregulated in various diseases, including neurodegenerative diseases and COPD. This suggests that MIR9-1HG may be a useful biomarker for these diseases.

Another potential use of MIR9-1HG as a biomarker is its role in stress response. MIR9-1HG has been shown to play a role in the regulation of cellular stress response, including the regulation of inflammation and cellular apoptosis. This suggests that MIR9-1HG may be a useful biomarker for stress-related diseases, such as cancer and neurodegenerative diseases.

In conclusion, MIR9-1HG is a protein that has been shown to play a role in various cellular processes, including cell signaling, DNA replication, and stress response. Its potential as a drug target and biomarker makes it an attractive target for further research. Further studies are needed to fully understand the role of MIR9-1HG in

Protein Name: MIR9-1 Host Gene

Functions: May play a role in FOS signaling pathways involved in development and remodeling of neurons. Promotes transcription of the FOS promoter

The "MIR9-1HG Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR9-1HG comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets